Literature DB >> 12021516

Oxidative stress and cardiovascular disease in dialyzed patients.

Mario Usberti1, Gian Mario Gerardi, Rosa Maria Gazzotti, Stefania Benedini, Silvana Archetti, Lidia Sugherini, Melissa Valentini, Paola Tira, Giuseppe Bufano, Alberto Albertini, Diego Di Lorenzo.   

Abstract

BACKGROUND/AIM: Oxidative damage has been suggested to play a key role in accelerated atherosclerosis and to be involved in cardiovascular disease (CVD) of dialyzed patients who are at risk of increased oxidative stress. The purpose of the present study was to examine the relationship between the severity of CVD and some markers of oxidative stress and antioxidant activity in our hemodialyzed (HD) and peritoneal dialysis (PD) patients.
METHODS: Plasma reactive oxygen metabolites, malondialdehyde and 4-hydroxynonenal (MDA-4HNE), thiols, alpha-tocopherol, and total antioxidant status (TAS) were measured in 55 HD and in 16 PD patients. CVD was considered as the result of variably combined cardiac, cerebral, and vascular pathologies which were scored and grouped in a single CVD index and analyzed with respect to the markers of the oxidative status. 16 normal subjects served as controls.
RESULTS: All patients showed evidence of increased oxidative stress which was more severe in HD than in PD patients and which was exacerbated by HD. When cardiac, cerebral, and vascular diseases were analyzed separately, plasma MDA-4HNE and TAS were significantly higher in more severely affected HD patients, but not in PD patients. In HD patients the CVD index was directly correlated with both MDA-4HNE and TAS (r = 0.42, p < 0.01; r = 0.39, p < 0.01) and inversely correlated with alpha-tocopherol (r = -0.32, p < 0.05). MDA-4HNE and TAS were directly correlated in HD patients and inversely correlated in control subjects.
CONCLUSIONS: Our data show that, in spite of increased antioxidant defense, there is a relationship between the degree of lipid peroxidation and the severity of CVD in HD patients. Moreover, these data underscore the utility of MDA-4HNE, alpha-tocopherol, and TAS in the evaluation of cardiovascular disease. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021516     DOI: 10.1159/000057601

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  16 in total

1.  Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis.

Authors:  Jacek Zachwieja; Marcin Zaniew; Waldemar Bobkowski; Ewa Stefaniak; Alfred Warzywoda; Danuta Ostalska-Nowicka; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

Review 2.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

3.  Correlations of cardiac function with inflammation, oxidative stress and anemia in patients with uremia.

Authors:  Heping Zhang; Lei Fan; Huawei Liao; Lirong Tu; Jie Zhang; Dan Xu; Jiangchao Feng
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

Review 4.  Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

Authors:  Jesse Dawson; Matthew Walters
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

5.  A fluorimetric semi-microplate format assay of protein carbonyls in blood plasma.

Authors:  Joy G Mohanty; Surya Bhamidipaty; Michele K Evans; Joseph M Rifkind
Journal:  Anal Biochem       Date:  2010-02-01       Impact factor: 3.365

6.  Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response.

Authors:  Tsutomu Sanaka; Takahiro Mochizuki; Eriko Kinugasa; Eiji Kusano; Shigeru Ohwada; Tsutomu Kuno; Kenichiro Kojima; Shuzo Kobayashi; Minoru Satoh; Noriaki Shimada; Kazushi Nakao; Ryoichi Nakazawa; Hideki Nishimura; Eisei Noiri; Takashi Shigematsu; Tadashi Tomo; Teiryo Maeda
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 8.237

7.  Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.

Authors:  Danuta Zwołińska; Władysław Grzeszczak; Maria Szczepańska; Katarzyna Kiliś-Pstrusińska; Krystyna Szprynger
Journal:  Pediatr Nephrol       Date:  2006-03-04       Impact factor: 3.714

Review 8.  Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.

Authors:  Kathy K Griendling; Rhian M Touyz; Jay L Zweier; Sergey Dikalov; William Chilian; Yeong-Renn Chen; David G Harrison; Aruni Bhatnagar
Journal:  Circ Res       Date:  2016-07-14       Impact factor: 17.367

9.  Cardiac Dysfunction in a Mouse Vascular Dementia Model of Bilateral Common Carotid Artery Stenosis.

Authors:  Lulu An; Michael Chopp; Alex Zacharek; Yi Shen; Zhili Chen; Yu Qian; Wei Li; Julie Landschoot-Ward; Zhongwu Liu; Poornima Venkat
Journal:  Front Cardiovasc Med       Date:  2021-06-11

10.  Comparison of plasma oxidative biomarkers and conformational modifications of hemoglobin in patients with diabetes on hemodialysis.

Authors:  Hadi Ansarihadipour; Hamidreza Dorostkar
Journal:  Iran Red Crescent Med J       Date:  2014-11-11       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.